ArticleKansas journal of medicine

Elevated Circulating Fibroblast Growth Factor 21 in Lean Type 2 Diabetes: Evidence of Metabolic Dysregulation in the Absence of Adiposity.

Sarah Nafea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.